← Open Payments lookup

ABIOLA IZEKOR: Open Payments

NPI 1194455741 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$582 in 42 payments from 9 companies in 2025. Trend: 2023 $60 · 2024 $111 · 2025 $582

Food & beverage: $575Education: $8
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.20$134
Otsuka America Pharmaceutical, Inc.5$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$101
ABBVIE INC.5$91
Takeda Pharmaceuticals U.S.A., Inc.4$69
Janssen Pharmaceuticals, Inc1$23
Vertical Pharmaceuticals, LLC1$23
Teva Pharmaceuticals USA, Inc.1$19
Collegium Pharmaceutical, Inc.1$17

Products named: Qelbree, REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX, SPRAVATO, Relexxii, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.